Dr. Niyati Anand Nathwani, MD

  • Rock Hill, SC
  • Hematologist and oncologist
NPI1730200031PAC ID9436242112
Medicare services, 2024
7,120
Medicare patients, 2024
263
Part D claims, 2024
674
Publications
2
Clinical trials
4
Practice address
1583 Health Care Dr, Rock Hill, SC 29732
Practice phone
Call (803) 329-7772
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Carolina Blood and Cancer Care Associates, P.A.

Rock Hill, South Carolina

See all 4 affiliations

Find Dr. Nathwani's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Niyati Anand Nathwani is a hematologist and oncologist in Rock Hill, South Carolina

Dr. Nathwani practices at Carolina Blood and Cancer Care Associates, P.A. in Rock Hill, South Carolina.

Dr. Nathwani's NPI, 1730200031, was assigned on April 3, 2007. Dr. Nathwani holds South Carolina license 29483.

NPI and contact details
Medicare PAC ID
9436242112
NPI enumeration date
April 3, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(803) 329-7772
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
52
Medical school graduation
2000

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Niyati Anand Nathwani practices at Carolina Blood and Cancer Care Associates, P.A. in Rock Hill, South Carolina

Dr. Nathwani's primary practice is Carolina Blood and Cancer Care Associates, P.A., at 1583 Health Care Dr, Rock Hill, SC 29732 in York County. The practice phone is (803) 329-7772.

  • Carolina Blood and Cancer Care Associates, P.A.
    1583 Health Care Dr, Rock Hill, SC 29732 · York CountyPhone(803) 329-7772

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Niyati Anand Nathwani is affiliated with 3 sites of care and 1 medical group

Dr. Nathwani's primary practice is Carolina Blood and Cancer Care Associates, P.A. in Rock Hill, South Carolina. Dr. Nathwani is also affiliated with MUSC Health Lancaster Medical Center. The medical group on file is Carolina Blood and Cancer Care. Dmand AI also links Dr. Nathwani to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Nathwani

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Niyati Anand Nathwani's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nathwani practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Carolina Blood and Cancer Care Associates, P.A.Available with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Nathwani practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Niyati Anand Nathwani is one of 157 hematologists and oncologists in South Carolina

Hematology and oncology is Dr. Nathwani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Nathwani's licenses on file in 2 states: South Carolina and California.

Specialties and state licenses

  • Hematology and oncology, South CarolinaPrimaryLicense 29483 · taxonomy 207RH0003X
  • California licenseLicense A84095

Hematologists and oncologists near Dr. Nathwani

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

157hematologists and oncologists in South Carolina
9hematologists and oncologists in Rock Hill

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Niyati Anand Nathwani billed Medicare for 7,120 services in 2024

CMS data shows 7,120 Medicare services from Dr. Nathwani across 25 procedure codes in 2024, for 263 Medicare patients. Medicare paid $174,451 for them.

Medicare services, 20247,120
Medicare patients263
Paid by Medicare$174,451
Procedure codes25

Dr. Nathwani's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 1,9422024: 3,975105%
Office and hospital visits
2023: 1,5872024: 1,6454%
Lab and pathology
2023: 1,1132024: 86322%
Tests and treatments
2023: 2582024: 31221%
Other services
2023: 1,4002024: 21385%
Surgery
2023: 472024: 112138%
Imaging
2023: 242024: 0100%

Where Dr. Nathwani's Medicare services took place, 2024

  • In an office7,103100%
  • In a facility170%

Dr. Nathwani compared with the South Carolina median for hematologists and oncologists, 2024

  • Dr. Nathwani
  • South Carolina median
Medicare services
7,120vs 1,5344.6 times
Medicare patients
263vs 38932% below
Part D claims
499vs 68627% below

Medians across 160 hematologists and oncologists in South Carolina with Dmand AI profiles that report each measure.

Dr. Nathwani's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Nathwani

Need commercial claims for Dr. Nathwani?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Nathwani and other hematologists and oncologists in South Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Niyati Anand Nathwani treated 263 Medicare patients in 2024, average age 74

CMS counts 263 Medicare patients who saw Dr. Nathwani in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nathwani's median patient age at 69, with 58% women.

Medicare patients, 2024263
Average age74
Average risk score1.70
Also on Medicaid13%

Dr. Nathwani's Medicare patients by age, 2024

Dr. Nathwani's Medicare patients by sex, 2024

  • Women16563%
  • Men9837%

Chronic conditions among Dr. Nathwani's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis47%
  4. Diabetes43%
  5. Chronic kidney disease37%
  6. Cancer35%
  7. Ischemic heart disease32%
  8. Anxiety29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Nathwani's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women58%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Niyati Anand Nathwani wrote 674 Medicare Part D claims in 2024

In 2024, Dr. Nathwani wrote 674 Medicare Part D claims for 121 patients. 55% of them were for generic drugs. CMS names the drug for 499 of them, across 17 drugs with 11 or more claims each, at $1,367,290 in total drug cost. In 2023, CMS named 335 claims across 13 drugs.

Part D claims, 2024674
Drugs named by CMS17
Total drug cost$1.4M
Part D patients121

Dr. Nathwani's Part D claims by kind of drug, 2024

  • Generic370 claims55%
  • Brand-name304 claims45%

Dr. Nathwani's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Nathwani's Part D claims, 2024

  • Opioids2%14 of 674 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3352024: 49949%

Drugs named by CMS: 17 in 2024, 13 in 2023.

See all prescribing by Dr. Nathwani

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Niyati Anand Nathwani scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nathwani for performance year 2024, reported individually. Dr. Nathwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nathwani as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Nathwani by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Niyati Anand Nathwani has 2 publications on record

Dmand AI links 2 papers to Dr. Nathwani. Dr. Nathwani has published most often in Am J Manag Care. Dr. Nathwani's most frequent co-author is Eric Kumar Singhi, MD.

Papers2

Dr. Nathwani's most frequent co-authors

Recent publications by Dr. Nathwani

See all 2 publications and co-authors

See who Dr. Nathwani researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Nathwani works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Niyati Anand Nathwani has worked on 4 clinical trials

Dmand AI links Dr. Nathwani to 4 clinical trials. Conditions studied include Breast Neoplasms, Hemoglobin SC Disease and Leukemia, Lymphocytic, Chronic, B-Cell.

Clinical trials with Dr. Nathwani by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Nathwani's trials

  • Breast Neoplasms
  • Hemoglobin SC Disease
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Rectal Neoplasms
  • Breast Diseases

Investigators on the most trials with Dr. Nathwani

Recent clinical trials with Dr. Nathwani

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Niyati Anand Nathwani received $45,710 in industry payments from 2016 to 2025

CMS Open Payments shows 1,145 general payments to Dr. Nathwani from 91 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. AstraZeneca Pharmaceuticals LP paid the most, $5,495.

General payments to Dr. Nathwani by program year, 2016 to 2025

General payments to Dr. Nathwani by kind, 2016 to 2025

$45.7Kin total
  • Food and beverage$23,45752%
  • Consulting fees$16,78537%
  • Speaker and faculty fees$1,8204%
  • Honoraria$1,5003%
  • Other$1,7204%

Companies that paid Dr. Nathwani the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Nathwani

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Niyati Anand Nathwani's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Niyati Anand Nathwani

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Niyati Anand Nathwani's NPI number?

Dr. Niyati Anand Nathwani's NPI number is 1730200031. It was assigned on April 3, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Niyati Anand Nathwani?

Dr. Niyati Anand Nathwani is a hematologist and oncologist in Rock Hill, South Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Niyati Anand Nathwani practice?

Dr. Nathwani practices at 1583 Health Care Dr, Rock Hill, SC 29732. Dr. Nathwani's primary practice is Carolina Blood and Cancer Care Associates, P.A. in Rock Hill, South Carolina. Dmand AI also links Dr. Nathwani to 1 group practice or clinic.

What is Dr. Niyati Anand Nathwani's office phone number?

The practice phone on file for Dr. Nathwani is (803) 329-7772.

What is Dr. Niyati Anand Nathwani's medical license number?

Dr. Nathwani holds South Carolina license 29483, one of the licenses on file in 2 states.

Which states has Dr. Niyati Anand Nathwani been licensed in?

Dmand AI has state licenses on file for Dr. Nathwani in South Carolina and California.

Which hospitals is Dr. Niyati Anand Nathwani affiliated with?

Dr. Nathwani is affiliated with MUSC Health Lancaster Medical Center.

What medical group is Dr. Niyati Anand Nathwani part of?

Dr. Nathwani is linked to Carolina Blood and Cancer Care.

Does Dr. Niyati Anand Nathwani accept Medicare?

Yes. CMS data shows Dr. Nathwani billed Medicare for 7,120 services in 2024, and Dr. Nathwani accepts Medicare assignment.

Does Dr. Niyati Anand Nathwani offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Nathwani as offering telehealth services.

Show 8 more questionsShow fewer questions

What is Dr. Niyati Anand Nathwani's MIPS score?

Dr. Nathwani's MIPS final score for performance year 2024 is 75 out of 100, reported individually.

How many Medicare patients does Dr. Niyati Anand Nathwani see?

CMS counts 263 Medicare patients who saw Dr. Nathwani in 2024, with an average age of 74.

What services does Dr. Niyati Anand Nathwani bill to Medicare?

In 2024, Dr. Nathwani's most billed Medicare services were injected or infused drug (J1437), injected or infused drug (J0897) and lab and pathology test (85025).

What drugs does Dr. Niyati Anand Nathwani prescribe most?

In 2024 Medicare Part D data, Dr. Nathwani's most prescribed drugs by claims were Anastrozole, Procrit and Eliquis.

Has Dr. Niyati Anand Nathwani received payments from drug or device companies?

CMS Open Payments shows $45,710 in general payments to Dr. Nathwani from 91 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Niyati Anand Nathwani been practicing?

Dr. Nathwani graduated from medical school in 2000, 26 years ago.

Does Dr. Niyati Anand Nathwani do research?

Dmand AI links 2 publications to Dr. Nathwani. Dr. Nathwani has worked on 4 clinical trials.

Who does Dr. Niyati Anand Nathwani publish with?

Dr. Nathwani's most frequent co-authors are Eric Kumar Singhi, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in South Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)